COVID-19 Digest: Neurological Manifestations of COVID-19

COVID-19 Digest: Neurological Manifestations of COVID-19

Accumulating clinical evidence suggests that many patients with COVID have neurological symptoms and that some may even present with neurologic manifestations of the disease. Most COVID patients have a cough, respiratory distress, and while clinicians often speak about how similar the presentations of patients with respiratory COVID are, it's worth looking at the possibility that COVID has atypical presentations, too.There's very good evidence that coronaviruses can infect all sorts of human cells--not just those in the respiratory tract. A few weeks ago we discussed ACE inhibitors and NSAIDs and SARS COV2 and you may remember that the virus attaches to the ACE2 receptor--a receptor which is found on a wide range of human cells. What are the chances the virus can infect a patients brain cells, cranial nerves, peripheral nerves?

Host: Elizabeth Esty, MD

Research By: Tanisha Crosby-Attipoe & Mason Tuttle

Sound Editing By: Stephen Bahmani

Time Stamps:

0:23 - Numbers

1:25 - Possible Neurological Manifestations of COVID

4:15 - What are the chances the virus can infect a patients brain cells, cranial nerves, peripheral nerves?

4:55 - The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients

8:24 - early neurological research from NEJM in February

9:10 - some early research indicated possible neurological manifestations

10:05 - COVID and serious CV incidents

10:40 - Italian Neurologists urge other nations to be alert for neuro presentations of COVID

11:11 - Case report in Radiology, COVID patient with encephalopathy

12:06 - Possible link with Guillain-Barré

References:

  1. Li Y-C, Bai W-Z, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. Journal of Medical Virology. 2020;92(6):552-555. doi:10.1002/jmv.25728
  2. Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19–associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features. Radiology. March 2020:201187. doi:10.1148/radiol.2020201187
  3. Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. April 2020. doi:10.1001/jamaneurol.2020.1127
  4. Li Y, Wang M, Zhou Y, et al. Acute Cerebrovascular Disease Following COVID-19: A Single Center, Retrospective, Observational Study. Rochester, NY: Social Science Research Network; 2020. doi:10.2139/ssrn.3550025
  5. Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? The Lancet Neurology. 2020;19(5):383-384. doi:10.1016/S1474-4422(20)30109-5

Further reading and listening:

https://www.medscape.com/viewarticle/928069

http://emguidewire.libsyn.com/rss

Episoder(1147)

Podcast 502: EMS Psych Clearance

Podcast 502: EMS Psych Clearance

Contributor: Aaron Lessen, MD Educational Pearls: Patients with psychiatric complaints are often complicated to disposition from the main ED, and many will require inpatient psychiatric stays Some he...

20 Sep 20192min

Podcast # 501: Take Down Potions

Podcast # 501: Take Down Potions

Author: Jared Scott, MD Educational Pearls: Study from Hennepin County EM studied the efficacy of different drugs for agitation, which included 737 patients Most patients in this study were male and ...

16 Sep 20193min

Colorado MAT Part 4: Buprenorphine in the Emergency Department

Colorado MAT Part 4: Buprenorphine in the Emergency Department

Treatment with buprenorphine is easier, less time consuming and far more effective for management of opioid withdrawal and OUD than standard care with clonidine, IVF, haldol and other symptomatic ther...

26 Aug 20191h 5min

Colorado MAT Part 3: Medications for MAT in the ED

Colorado MAT Part 3: Medications for MAT in the ED

There are three MAT drugs available to treat addiction: naltrexone (brand name Vivitrol), methadone (brand names Dolophine or Methadose) & buprenorphine (brand name Suboxone, Subutex, and Sublicade). ...

26 Aug 201927min

Colorado MAT Part 2: Medication Assisted Treatment

Colorado MAT Part 2: Medication Assisted Treatment

Medication Assisted Treatment or (Medication for Addiction Treatment) is an important frontier in ED care of patients with Opioid Use Disorder. Naltrexone, methadone and buprenorphine are the medicati...

26 Aug 201928min

Colorado MAT Part 1: Understanding Addiction & Opioid Use Disorder

Colorado MAT Part 1: Understanding Addiction & Opioid Use Disorder

Addiction is widely misunderstood by the public and by many healthcare providers. It is not taught in most medical schools. Combating the opioid epidemic will require providers to understand Opioid U...

26 Aug 201939min

Podcast #500: 2018-19 Rapid Fire EM Literature Review

Podcast #500: 2018-19 Rapid Fire EM Literature Review

Author: Dave Saintsing Educational Pearls: Poor sleep is an independent risk factor for development of health problems such as type 2 diabetes. A 2019 study, randomized participants to 3 groups: 9 h...

24 Aug 201914min

Podcast #499: Posterior Circulation Ischemia

Podcast #499: Posterior Circulation Ischemia

Podcast # 499: Posterior Circulation Strokes Contributor: Neal O'Connor, MD Educational Pearls: Dizziness is a very common complaint in the emergency department, but how can we find patients with a d...

22 Aug 201912min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
rekommandert
jss
liberal-halvtime
rss-rekommandert
sinnsyn
forskningno
villmarksliv
rss-paradigmepodden
fjellsportpodden
dekodet-2
pod-britannia
rss-overskuddsliv
tidlose-historier
hva-er-greia-med
tomprat-med-gunnar-tjomlid
katastrofe-i-hjernen
rss-lundqvist-podden
rss-nysgjerrige-norge